The short answer
Kava may add to fentanyl-related drowsiness and impairment. Exact-pair clinical risk has not been quantified, but fentanyl’s serious CNS-depressant warning supports review before combining them.
What this answer covers
Piper methysticum beverages or extracts; strength and co-ingredients vary.
- Supplement or preparation
- Piper methysticum
- Medication ingredient
- fentanyl
Why the combination matters
Fentanyl can impair consciousness and breathing. Its labels warn that other CNS depressants can intensify those effects. Supplement guidance advises caution with other sedating substances.
The evidence has limits
No inspected study measures this exact combination’s adverse-event rate. A kava and valerian trial found no clear sleep or anxiety benefit, which does not establish absence of sedation or safety with fentanyl.
Confirm the preparation and fentanyl formulation
A skin patch produces prolonged exposure and is restricted to opioid-tolerant patients; injection is used in a monitored clinical setting. These differences matter when evaluating a supplement.
Review use before a procedure or a change
Tell the prescribing or anesthesia team about use before treatment. No short spacing interval has been shown to make co-use safe. Avoid driving while impaired; slow breathing or unusual difficulty waking requires emergency help.
Evidence and practical considerations
Side effects & toxicity
Conditional additive-sedation precaution, not exact-pair observed severe toxicity or incidence; preparation and fentanyl route limits retained.
- Exact scope
- Piper methysticum beverages or extracts; strength and co-ingredients vary. with Fentanyl4337 IN; human IV/IM citrate or transdermal product with opioid-tolerance and route boundaries.
- Medication form and route
- intravenous medication; intramuscular medication; transdermal medication; oral supplement
What remains uncertain
- No unmeasured pair incidence, blanket class transfer or arbitrary spacing interval.
Factors that may matter: Preparation; Dose; Other medicines; Organ function.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed fentanyl
Opioid respiratory depression/CNS-depressant warnings and serotonin-syndrome precautions with serotonergic drugs.
How this applies: Exact fentanyl RxCUI 4337 IN, with stated salt/formulation/route bridge.
Not transdermal or transmucosal dosing; no supplement-specific event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed fentanyl
CNS-depressant and serotonergic interaction warnings; heat and formulation-specific exposure risks.
How this applies: Exact fentanyl RxCUI 4337 IN, with stated salt/formulation/route bridge.
Not appropriate for opioid-naive patients or acute postoperative pain; surgical IV studies cannot define patch co-use safety.
Source 3: federal supplement safety guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Users of the specified supplement.
Kava should not be used with other sedating substances. Various kava products have been linked to rare liver injury, sometimes serious or fatal.
How this applies: Original source interpreted for fentanyl only within the stated preparation and endpoint limits.
Not a direct fentanyl combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 391 participants with anxiety and insomnia.
Neither botanical improved its primary anxiety/insomnia outcome over placebo.
How this applies: Original source interpreted for fentanyl only within the stated preparation and endpoint limits.
Not a direct fentanyl combination trial; original preparation, dose and endpoint limits apply. No exact-pair adverse-event rate or protective spacing established.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact fentanyl article with formulation-specific evidence and uncertainty. | |
| Research summary published |
Article revision: 1cef7c52496046f9
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.